Response in the placebo group in randomized controlled trials for moderate-to-severe psoriasis

被引：0
|
作者：
Afach, Sivem [1 ]
Le Cleach, Laurence [1 ,2 ]
Sbidian, Emilie [1 ,2 ]
机构：
[1] Univ Paris Est Creteil, UPEC EpiDermE EA, Creteil, France
[2] UPEC, Hop Univ Henri Mondor, AP HP, Dept Dermatol, Creteil, France
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
32102
引用
收藏
页码：AB103 / AB103
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: A phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL)
    Tsai, Tsen-Fang
    Ho, Ji-Chen
    Song, Michael
    Szapary, Philippe
    Guzzo, Cynthia
    Shen, Yuang-Kuang
    Li, Shu
    Kim, Kwang-Joong
    Kim, Tae-Yoon
    Choi, Jee-Ho
    Youn, Jai-Il
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2011, 63 (03) : 154 - 163
  • [42] Tofacitinib for the treatment of moderate-to-severe psoriasis
    Chiricozzi, Andrea
    Faleri, Sara
    Saraceno, Rosita
    Bianchi, Luca
    Buonomo, Oreste
    Chimenti, Sergio
    Chimenti, Maria Sole
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (04) : 443 - 455
  • [43] Managing Moderate-to-Severe Psoriasis in the Elderly
    Nicola Balato
    Cataldo Patruno
    Maddalena Napolitano
    Angela Patrì
    Fabio Ayala
    Raffaele Scarpa
    Drugs & Aging, 2014, 31 : 233 - 238
  • [44] Risankizumab in moderate-to-severe plaque psoriasis
    Serrano, Linda
    Maloney, Victoria
    Gordon, Kenneth B.
    IMMUNOTHERAPY, 2019, 11 (16) : 1357 - 1370
  • [45] Managing Moderate-to-Severe Psoriasis in the Elderly
    Balato, Nicola
    Patruno, Cataldo
    Napolitano, Maddalena
    Patri, Angela
    Ayala, Fabio
    Scarpa, Raffaele
    DRUGS & AGING, 2014, 31 (04) : 233 - 238
  • [46] Safety of tildrakizumab for moderate-to-severe chronic plaque psoriasis: Pooled analysis of three randomized controlled studies
    Blauvelt, Andrew
    Reich, Kristian
    Papp, Kim A.
    Kimball, Alexa B.
    Gooderham, Melinda
    Tyring, Stephen K.
    Sinclair, Rodney
    Thaci, Diamant
    Li, Qing
    la Rosa, Carmen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB252 - AB252
  • [47] Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis
    María C. Ovejero-Benito
    Ester Muñoz-Aceituno
    Alejandra Reolid
    Miriam Saiz-Rodríguez
    Francisco Abad-Santos
    Esteban Daudén
    American Journal of Clinical Dermatology, 2018, 19 : 209 - 222
  • [48] Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis
    Korman, Neil J.
    Sofen, Howard
    Fretzin, Scott
    Rich, Phoebe
    Zhao, Yang
    Herrera, Vivian
    Nyirady, Judit
    Williams, Nicole
    Mordin, Margaret
    Tyring, Stephen
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2017, 28 (05) : 384 - 389
  • [49] Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis
    Ovejero-Benito, Maria C.
    Munoz-Aceituno, Ester
    Reolid, Alejandra
    Saiz-Rodriguez, Miriam
    Abad-Santos, Francisco
    Dauden, Esteban
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (02) : 209 - 222
  • [50] Treatment of moderate-to-severe plaque psoriasis
    Salgo, R.
    Thaci, D.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06): : 701 - 711
12345